These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 31261543)
1. Comparisons of therapeutic outcomes in patients with nonampullary duodenal neuroendocrine tumors (NADNETs): A multicenter retrospective study. Lee SW; Sung JK; Cho YS; Bang KB; Kang SH; Kim KB; Kim SH; Moon HS; Song KH; Kim SM; Chung IK; Lee DS; Jeong HY; Youn SJ Medicine (Baltimore); 2019 Jun; 98(26):e16154. PubMed ID: 31261543 [TBL] [Abstract][Full Text] [Related]
5. Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature. Dasari BVM; Al-Shakhshir S; Pawlik TM; Shah T; Marudanayagam R; Sutcliffe RP; Mirza DF; Muiesan P; Roberts KJ; Isaac J J Gastrointest Surg; 2018 Sep; 22(9):1652-1658. PubMed ID: 29869091 [TBL] [Abstract][Full Text] [Related]
6. Clinical features and prognostic factors of duodenal neuroendocrine tumours: A comparative study of ampullary and nonampullary regions. Fang S; Shi YP; Wang L; Han S; Shi YQ World J Gastrointest Oncol; 2024 Mar; 16(3):907-918. PubMed ID: 38577444 [TBL] [Abstract][Full Text] [Related]
7. Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study. Li QL; Zhang YQ; Chen WF; Xu MD; Zhong YS; Ma LL; Qin WZ; Hu JW; Cai MY; Yao LQ; Zhou PH World J Gastroenterol; 2012 Oct; 18(40):5799-806. PubMed ID: 23155323 [TBL] [Abstract][Full Text] [Related]
8. Selection of appropriate endoscopic therapies for duodenal tumors: an open-label study, single-center experience. Matsumoto S; Yoshida Y World J Gastroenterol; 2014 Jul; 20(26):8624-30. PubMed ID: 25024618 [TBL] [Abstract][Full Text] [Related]
9. Surgical outcomes of patients with duodenal vs pancreatic neuroendocrine tumors following pancreatoduodenectomy. Dong DH; Zhang XF; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Spolverato G; Maithel SK; Pawlik TM J Surg Oncol; 2020 Sep; 122(3):442-449. PubMed ID: 32470159 [TBL] [Abstract][Full Text] [Related]
10. Pancreaticoduodenectomy for nonampullary duodenal lesions: indications and results. Shamali A; McCrudden R; Bhandari P; Shek F; Barnett E; Bateman A; Abu Hilal M Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1388-1393. PubMed ID: 27603299 [TBL] [Abstract][Full Text] [Related]
11. Impact of margin status on outcomes after endoscopic resection of well-differentiated duodenal neuroendocrine tumors. Ragheb J; Mony S; Klapman J; Erim T; Reagan A; Butler R; Dong Y; Cruise M; Centeno BA; Bejarano P; Stevens T; Hayat U; Bhatt A Gastrointest Endosc; 2021 Sep; 94(3):580-588. PubMed ID: 33676923 [TBL] [Abstract][Full Text] [Related]
12. Endoscopic resection for duodenal subepithelial tumors: a single-center experience. Kim TW; Kim GH; Park DY; Ahn S; Lim W; Lee BE; Song GA Surg Endosc; 2017 Apr; 31(4):1936-1946. PubMed ID: 27553800 [TBL] [Abstract][Full Text] [Related]
13. Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management. Weatherall T; Denbo J; Sharpe J; Martin M; O'Brien T; Gupta R; Groshart K; Behrman S; Dickson P World J Surg; 2017 Mar; 41(3):844-850. PubMed ID: 27743074 [TBL] [Abstract][Full Text] [Related]
14. Usefulness and safety of endoscopic treatment for nonampullary duodenal adenoma and adenocarcinoma. Seo JY; Hong SJ; Han JP; Jang HY; Myung YS; Kim C; Lee YN; Ko BM J Gastroenterol Hepatol; 2014 Sep; 29(9):1692-8. PubMed ID: 24720570 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor. Kim J; Kim JH; Lee JY; Chun J; Im JP; Kim JS BMC Gastroenterol; 2018 Jun; 18(1):77. PubMed ID: 29866049 [TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors. Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879 [TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of endoscopic resection for duodenal neuroendocrine tumors. Yi K; Kim GH; Kim SJ; Choi CW; Lee MW; Lee BE; Song GA Sci Rep; 2023 Oct; 13(1):17908. PubMed ID: 37863959 [TBL] [Abstract][Full Text] [Related]
18. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors. Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453 [No Abstract] [Full Text] [Related]
19. Clinical outcome of endoscopic resection for nonampullary duodenal tumors. Nonaka S; Oda I; Tada K; Mori G; Sato Y; Abe S; Suzuki H; Yoshinaga S; Nakajima T; Matsuda T; Taniguchi H; Saito Y; Maetani I Endoscopy; 2015 Feb; 47(2):129-35. PubMed ID: 25314330 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China. Chen X; Li B; Wang S; Yang B; Zhu L; Ma S; Wu J; He Q; Zhao J; Zheng Z; Li S; Wang T; Liang L Scand J Gastroenterol; 2019 Mar; 54(3):384-389. PubMed ID: 31037980 [No Abstract] [Full Text] [Related] [Next] [New Search]